Neurocrine Biosciences (NBIX) Book Value

Price: $106.73
Market Cap: $10.56B
Avg Volume: 1.57M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.334
52W Range: $84.23-157.98
Website: Neurocrine Biosciences

What is Neurocrine Biosciences's Book Value?

  • Neurocrine Biosciences's annual Book Value is $2.59B.
  • Neurocrine Biosciences's quarterly Book Value is $2.59B.

What is Book Value?

Book Value represents the total value of a company's assets that shareholders would theoretically receive if a company were liquidated. It is calculated as the total assets minus intangible assets and total liabilities.

How is Book Value calculated?

Book Value is calculated using the following formula:

Book Value = Total Assets - Intangible Assets - Total Liabilities

Related Metrics

Other important metrics to assess Neurocrine Biosciences's financial health include:

  • Book Value per Share - measures the per-share value of a company based on its equity:
    • Annual: $25.79
    • Quarterly: $25.79
  • Tangible Book Value per Share - measures the per-share value of a company's tangible assets:
    • Annual: $25.43
    • Quarterly: $25.43

These metrics provide insights into Neurocrine Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Book Value

$2.59B

Quarterly Book Value

$2.59B

Neurocrine Biosciences Historical Book Value
$3.00B$3.00B$2.40B$2.40B$1.80B$1.80B$1.20B$1.20B$600.00M$600.00M$0.00$0.00Book Value20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Book Value per Share
$30.00$30.00$24.00$24.00$18.00$18.00$12.00$12.00$6.00$6.00$0.00$0.00Book Value per Share20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Tangible Book Value per Share
$30.00$30.00$24.00$24.00$18.00$18.00$12.00$12.00$6.00$6.00$0.00$0.00Tangible Book Value per Share20162016201720172018201820192019202020202021202120222022202320232024202420252025

Neurocrine Biosciences Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Book Value Book Value Change Book Value per Share Tangible Book Value per Share
2024 $2.59B 16.03% 25.79 25.43
2023 $2.23B 30.69% 22.85 22.48
2022 $1.71B 24.29% 17.83 17.44
2021 $1.37B 22.00% 14.52 14.52
2020 $1.13B 76.83% 12.10 12.10
2019 $636.90M 32.48% 6.95 6.95
2018 $480.76M 29.19% 5.04 5.04
2017 $372.14M 18.19% 4.23 4.23
2016 $314.88M -25.82% 3.64 3.64
2015 $424.45M N/A 5.02 5.02

Related Metrics

Explore detailed financial metrics and analysis for NBIX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio